Beyond Benioff: Salesforce Ready Without Its Founder
Salesforce faces leadership questions as founder Marc Benioff approaches three decades at the helm. The company is st...
Wealth Planning Tools And Resources
Wealth planning tools are essential for financial success. Discover resources that can help you achieve your financial aspirations.
28,655 articlesStock Market Today: Energy Surges on New Stake Disclosure
A renewed focus on energy equities is lifting parts of the market today. This piece breaks down what’s driving the mo...
The Case Non-QM: Serving American Homebuyers Today and Beyond
Non-QM mortgage products are expanding to serve gig workers and freelancers, signaling a major shift in access to hom...
These Underperforming Dow Stocks Have Common Traits
Three Dow components lag this year, sharing three pressure points that investors still see as catalysts. Wall Street ...
Thursday Reads for Investors: 10 Must-See Thursday Reads
Turn Thursdays into your smartest investing ritual. This guide curates 10 essential thursday reads and translates the...
Intel vs TSM: Which Chip Is a Better Investment Right Now?
Intel and TSMC reported divergent earnings trajectories as AI demand reshapes chips. This analysis weighs growth, mar...
Traders Sue Polymarket Over Disputed Market Resolution
Two traders file a civil suit accusing Polymarket of misresolving a Strategy bitcoin sale market after a late May dis...
A Simple Reason American Express Looks Strong Ahead of July 24 Earnings
With American Express set to report on July 24, analysts say a durable franchise, disciplined capital returns, and a ...
Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Live: Oracle (ORCL) Reports Q3 Earnings After Bell Tonight
Oracle is slated to post Q3 results after the market closes, with a 5:00 p.m. ET conference call. Here’s what to watc...
This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Maze Therapeutics CSBO Sells: Reading Insider Moves
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status